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Introduction
Julius Richard Petri introduced the Petri dish to microbiology in 1887,1 making the
culturing of single or multiple microbes on a nutrient medium in a Petri dish to be a
130-year-old technology. However, bacteria seldom occur in nature as a pure culture
of a single species, but rather exist and participate in a community of microbes, that
is, the microbiome.2 In the case of a human host, the microbiome occupies several
specific anatomic niches, for example, hair, skin, gastrointestinal tract, urogenital tract,
vagina, nasal, and paranasal sinuses, and the oral cavity.2–4 Under the best of conditions,
each of these microbiome niches represents a species-balanced community which is
important to the establishment and maintenance of human health.3,5
Current evidence suggests an association between a dysbiotic oral microbiome,
manifest as periodontal disease, and a variety of systemic diseases. For example, moderate and severe periodontitis have been associated with development and progression of
atherosclerosis,6–8 cardiovascular disease,9–11 stroke,12–14 complications of diabetes,15–17
Alzheimer’s disease,18–20 and adverse pregnancy outcomes.21–27 The common denominator for this mixture of disease associations appears to be the host inflammatory response
and specific microbial pathogens.28–30 Because inflammatory periodontal disease
is, for the most part, preventable,31 intervention strategies that result in better oral/
systemic health should be considered for reasons of public health. More specifically,
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Abstract: Significant evidence supports an association between periodontal pathogenic bacteria
and preterm birth and preeclampsia. The virulence properties assigned to specific oral pathogenic
bacteria, for example, Fusobacterium nucleatum, Porphyromonas gingivalis, Filifactor alocis,
Campylobacter rectus, and others, render them as potential collaborators in adverse outcomes
of pregnancy. Several pathways have been suggested for this association: 1) hematogenous
spread (bacteremia) of periodontal pathogens; 2) hematogenous spread of multiple mediators of
inflammation that are generated by the host and/or fetal immune response to pathogenic bacteria;
and 3) the possibility of oral microbial pathogen transmission, with subsequent colonization, in
the vaginal microbiome resulting from sexual practices. As periodontal disease is, for the most
part, preventable, the medical and dental public health communities can address intervention
strategies to control oral inflammatory disease, lessen the systemic inflammatory burden, and
ultimately reduce the potential for adverse pregnancy outcomes. This article reviews the oral,
vaginal, and placental microbiomes, considers their potential impact on preterm labor, and the
future research needed to confirm or refute this relationship.
Keywords: periodontal disease, preterm labor, oral microbiome, vaginal microbiome, bacteria,
pregnancy, infant, premature birth, low birth weight
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such strategies should be aimed at populations susceptible to
atherosclerosis-related diseases (ie, cardiovascular, stroke,
diabetes, and possibly Alzheimer’s disease) and women of
child-bearing age.
Significant evidence is available to consider that the
majority of preterm births due to infection result from an
ascendancy of bacterial pathogens from the vaginal microbiome to infect the clinically sterile intrauterine cavity
consisting of the placenta, amniotic fluid, and fetus.31–34
This does not preclude the possibility of a hematogenous
spread (bacteremia) of pathogenic microbes and inflammatory mediators originating from other sources, including
untreated periodontal disease, and their contributions to an
adverse pregnancy outcome, such as preeclampsia, preterm
birth and low birth weight, fetal growth restriction, and
fetal loss.30,35,36

The oral microbiome
As a result of multiple ecologic determinants, the human oral
cavity presents a prodigious and multifarious microbiota.37–41
In a state of health, the oral microbiota maintain a symbiotic
relationship with their host. However, an imbalance or maladaptation within the oral microbial community (dysbiosis)
commonly results in development of a dental disease.42,43
In this regard, dental caries, gingivitis, and chronic or aggressive forms of periodontitis are the most common expressions
of oral disease.39,44–46
Chronic periodontitis is a highly prevalent, dysbiosisinitiated, inflammatory condition that results in destruction of
the supporting tissues of the teeth. This destructive process,
a host response to pathogenic bacteria and their toxins such
as cytolytic enzymes and lipopolysaccharides, is mediated by
a proinflammatory cellular response involving neutrophils,
lymphocytes, macrophages, and osteoclasts.45–50 The host
response also generates a variety of inflammatory mediators, such as interleukin (IL)-1β, tumor necrosis factor-α,
IL-6, prostaglandin E2, matrix metalloproteinase-8 and -9,
which, in turn, can have a downstream effect on other
organ systems by contributing to the body’s overall inflammatory burden.51–56
Through reverse transcription-polymerase chain reaction,
microarray, and pyrosequencing technology, the microbiome
of the human oral cavity has been found to be made up of a
minimum of 700+ distinct microbial species, with suggestions that this number may be as high as 1,200–1,500.39–41 By
comparison, the microbial flora consistently associated with
chronic periodontitis is reported to involve only a limited
number of species.39,40,57 Dominating, in terms of virulence,
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among the periodontitis-associated bacterial species are
mainly Gram-negative anaerobic bacteria, such as Porphyromonas gingivalis, Filifactor alocis, multiple species of
Prevotella, particularly, Prevotella intermedia, Tannerella
forsythia, multiple species of Treponema, particularly,
Treponema denticola, Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum, Parvimonas micros, Campylobacter recta, multiple species of Eubacterium, and multiple
species of Bacteroides.37,39–41,57–59 Interestingly, two of these
bacteria are considered “keystone” microbes, Po. gingivalis
and Fi. alocis. Keystone microbes are characterized by their
relatively low numbers in a biofilm community and inherent virulence factors that allow manipulation of the host
innate immune system and remodeling of a normally benign
microbiota into one that is dysbiotic.42,60–64 In addition to
being keystone microbes, both Po. gingivalis and Fi. alocis
are highly invasive microbes, a virulence factor that allows
avoidance of the host immune response.65–69 Other microbes
associated with periodontitis (T. denticola, Pr. intermedia,
Fu. nucleatum, A. actinomycetemcomitans, C. rectus, and
so on) are also known to exhibit tissue-invasive tendencies, particularly in severe disease.70–72 This combination of
tissue invasiveness, when combined with multiple transient
bacteremias (common in patients with periodontal disease
during mastication, oral hygiene, or dental treatment) leads
to a body-wide dissemination of bacteria and activation of
systemic inflammation-causing organ system complications
and, in the case of pregnancy, adverse outcomes.21,25,73–77

Prevalence of periodontitis
Combined data from the 2009 to 2010 and the 2011 to 2012
cycles of the National Health and Nutrition Examination
Survey revealed that 46% of US adults, aged 30 years,
representing ~65 million people, exhibited some degree of
periodontitis.78,79 Of this group, 8.9% presented with severe
periodontitis, which equates to ~12.6 million people.79
Increased prevalence rate of periodontitis was associated with
increasing age, male gender, and current tobacco smoking.
Prevalence rates based on ethnic grouping were rather revealing when considered in terms of access to care issues, that
is, Hispanic (63.5%), non-Hispanic blacks (59.1%), nonHispanic Asian Americans (50%), and non-Hispanic whites
(40.8) were predominantly affected.79
Worldwide, severe periodontitis is estimated to be present in 10%–15% of the adult population,80,81 with prevalence
varying considerably from country to country. For example,
20% of adults between the ages of 20 and 79 years in a large
West Pomerania (Germany) study were reported to exhibit
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severe periodontitis.71 The same study reported a prevalence
rate of 35.3% of the population presenting with moderate
periodontitis.71
Studies from India report that prevalence of periodontitis
with attachment loss of 3 mm (moderate to severe disease)
varies from 46% to 78%.82 However, depending on the age
group and rural vs urban populations, the prevalence of periodontal disease in India can vary from ≈50% to a maximum
of 91%.82–88 Periodontal disease prevalence data collected
since the year 2000 and for women of reproductive age
(18–45 years) are sparse. The data, not unexpectedly, show
that both severity and prevalence of the disease increase with
increasing age.83–88
Specific to reproductive aged women, Bansal et al,84 in
their study that included 205 females, reported that 6.58%
of those aged between 20 and 24 years exhibited bleeding
on probing (BOP) and 50.61% of subjects aged between
25 and 34 years presented with visible amounts of dental
calculus. The authors did not address severity of disease in the
traditional manner, but rather assessed the need for treatment
using the Community Periodontal Index of Treatment Needs
(CPITN).89 A CPITN score of 1= BOP; score of 2= presence of
supra- or subgingival calculus; score of 3= periodontal probing
depth of 3.5–5.5 mm; score of 4= probing depth 5.5 mm.
Thus, based on the CPITN data, severity of disease in the
Bansal et al84 study is judged to be slight to moderate.
Batra et al85 reported that 45.5% of females, in a rural
population, aged 20–29 years and 83.9% of those aged 30–39
years had CPITN scores of 2 or greater. Such a range of
scores would indicate periodontal disease severity ranging
from slight to severe.
Other studies addressing disease prevalence in women
of reproductive age are equally imprecise. For example,
studies by Grewal et al87 and Rao et al88 both assessed rural
Indian populations from Punjab and Mustabad, Krishna
District, respectively. One study used the CPITN87 and
the other the Community Periodontal Index88 indices for
screening of patients and approximation of disease severity.
Females represented ≈55% of the population in both studies.
In general, both studies reported that females, regardless of
age group, had a greater prevalence of periodontal disease
than did males, roughly 55% vs 44%.
A study by Murthy et al90 assessed the association of
periodontal disease to preterm birth and low birth weight.
The study evaluated 240 primigravida Indian women equally
divided between those with and without periodontitis. All
participants exhibited BOP, 48% exhibited dental calculus
accumulation, and those with periodontitis had pocketing of
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3.5–4.5 mm (slight to moderate disease). The study reported
that periodontitis and anemia were independent risk factors
for low birth weight, in spite of the slight to moderate severity
of periodontal disease.
The CPITN index has been used by the majority of
epidemiology studies to express severity of disease and
treatment needs in Indian populations. However, as noted
by Chandra et al86 and Shewale et al,91 the CPITN is known
to grossly underestimate the levels of moderate and severe
disease. Given the presentation of data using CPITN from
various studies and the issue of underestimation of disease
severity, one can still reasonably conclude that periodontal
disease in Indian women of reproductive age (18–45 years)
ranges from 10% to 35%, increasing in both prevalence and
severity with increasing age.

The vaginal microbiome
The Human Microbiome Project (2012)92 reported that the
vaginal microbiome exhibits an uncomplicated microbial
diversity, compared to that of the gastrointestinal tract or the
oral cavity. In healthy subjects, there appears to be minimal
variation in the diversity of the vaginal microbiota.93 Species
of Lactobacillus typically dominate the vaginal microbiota,
comprising greater than 70% of the microflora.94 As in other
bacterial communities, the dominance of one or more species,
in this case Lactobacilli, generally prevents colonization by
undesirable extrinsic species and, thereby, may provide a
protective function.93–96 Yet, Hyman et al97 report that changes
in the proportions of Lactobacillus in the vaginal microbiome
and the presence of noxious bacteria were not correlated
to preterm birth. The authors noted that race/ethnicity and
sampling location likely impact determination of the vaginal
microbiome. This latter statement was supported by Green
et al98 and Prince et al99 in their respective reviews in which
it was noted that the vaginal microbiome can fluctuate during
various states of health, during hormonal fluctuations (ie,
menstrual cycle and menopause), and between women of
various ethnicities. A recent study by Hickey et al100 further
supports the impact of hormonal change on the vaginal
microbiota, reporting that puberty and initiation of cyclic
menstruation have profound effects. Last, Prince et al 99
reported that during pregnancy, there is an overall increase
of bacteria from the taxa of Lactobacillus, Clostridiales,
Bacterodies, and Actinomycetales. However, none of these
taxa were noted as having any negative effects on pregnancy.
Prince et al99 did note that most of the studies looking at the
vaginal microbiome are cross-sectional, which allows for the
characterization of a pregnancy and gestational age-common
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microbiome, but lacks the capacity for description of dynamic
changes that may occur in individuals over time.
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The placental microbiome
While the placenta has long been considered to be sterile in
normal gestation,99 several authors93,101–104 have now reported
that the placenta in healthy pregnancies has its own resident
microbiome. Indeed, it appears that the presence of bacterial infiltration of the placenta, without histologic evidence
of infection, is not an unusual observation.101,103,104 Combs
et al105,106 have shown that there is no association of preterm
birth with a relatively benign intra-amniotic invasion of
bacteria, that is, in the absence of inflammation. In contrast,
preterm birth rates were higher in the presence of a combination of bacterial invasion and concomitant inflammatory
response, indicated by elevated amniotic fluid levels of IL-6.
Interestingly, in their initial study, Combs et al105 diagnosed a
microbial infection or severe inflammation (defined as amniotic fluid levels of IL-6 11.3 ng/mL) in 63 of 305 (≈20%)
women with preterm labor. Of those identified with microbial
infection (n=27), the offending microbe in roughly 50% of
the patients was of a genus and species commonly found
in the oral cavity, for example, Fu. nucleatum, Bergeyella
sp., Clostridium sp., Actinomyces sp., Peptostreptococcus
(a.k.a. Parviomonas) sp., and Candida albicans.
Given this observation, one might argue that the mere
presence of bacteria in the placenta is not the important
determinant of preterm birth. Rather the specific types of
bacterial populations present would seem to play a bigger
role. For example, the presence of “keystone” microbes, such
as Po. gingivalis and/or Fi. alocis, both having the ability to
interact with previously benign microbes, converting them
into active pathogens, may play a sinister role in microbial
dysbiosis that leads to an adverse pregnancy outcome. Given
this line of thought, it is interesting to note that Aagaard
et al102 reported that the bacterial taxonomic profile of the
placenta microbiome was more similar to that of the oral
cavity than to skin, nasal, vaginal, or the gastrointestinal
floras of nonpregnant control patients.
The placental microbiome was found to contain,
among others, bacteria belonging to the following phyla:
Firmicutes, Tenericutes, Proteobacteria, Bacteroidetes,
and Fusobacteria.102 The majority of bacterial species in
these phyla are Gram-negative, anaerobic, and common to
the human oral cavity. As suggested by Stout et al,101 the
similarities of the two microbiomes (vaginal and oral) may
indicate a hematogenous spread of the associated microbes.
A hematogenous spread of oral microbes, in turn, presents
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the possibility of their participation in the pathogenic mechanisms of preterm birth or other adverse pregnancy outcomes,
such as preeclampsia or fetal death.24,107–112

Bacteria and adverse pregnancy
outcomes
Infection-related preterm birth is reported as the leading cause of
infant mortality and morbidity.110 Evidence indicates that ~40%
of preterm births are vaginal and intrauterine infection related
and ~50% are associated with intra-amniotic infections.97,113,114
Given this background, an understanding of the origin of the
offending bacteria and routes of invasion of the placenta and
amniotic cavity becomes requisite. A review by Mendez et al32
concluded that the most common intra-amniotic bacterial taxa
were species associated with the vagina, although other species
were commonly associated with the oral cavity, gastrointestinal
and respiratory tracts. The authors concluded that the collective
data indicate a primary role for the ascending route of infection during pregnancy and a possible secondary role for the
hematogenous route of invasion.
In spite of the evidence and the biologic plausibility
supporting a hematogenous dissemination of oral microbes
and a role in adverse pregnancy outcomes,115–118 a paradox
remains. Results of intervention studies in which periodontal
disease was treated in the second trimester of pregnancy
have generated conflicting results.30,119–127 Reasons for this
lack of effect may involve several design and methodology
issues, such as 1) variations in the comprehensive nature of
the periodontal examination, that is, partial vs full-mouth
examination, which result in an imprecise determination of
disease severity; 2) variations in the consistency in timing
of the periodontal examination with respect to gestational
age; 3) lack of masking of examiners; 4) lack of multivariable analyses that considered confounders30; 5) variations in
treatment protocols; 6) treatment failed to adequately reduce
periodontal inflammation; and 7) treatment rendered in the
second trimester may be too late to elicit a beneficial effect on
pregnancy outcomes. The obvious intervention study remains
to be done, that is, definitive treatment of inflammatory periodontal disease prior to conception, followed by periodontal
maintenance every 3 months during pregnancy.
One might argue that the hematogenous spread of oral
microbial pathogens (bacteremia) is prevented by systemic
“biologic filters” such as the reticuloendothelial systems of
the liver and spleen and the maternal–fetal barrier. However, multiple avenues exist for how bacteria of oral origin
can participate in placental and intrauterine infections.
Take for example, Fu. nucleatum, a highly prevalent oral
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microbial species that is associated with both periodontal
disease128,129 and adverse pregnancy complications.130,131
Several investigators132,133 have shown that Fu. nucleatum can
be induced to express adhesin FadA, a protein that interacts
with E-cadherin which is a major mediator of cell-to-cell
attachment of epithelial and endothelial cells. Fu. nucleatum
adheres to and invades host cells and facilitates invasion by
otherwise noninvasive bacteria.134–136 Indeed, host cell attachment and invasion by Fu. nucleatum has been shown to play
a critical role in intrauterine infection.133,136
A second consideration is the potential role for
Po. gingivalis, mentioned earlier along with Fi. alocis, as
a “keystone” microbe. Po. gingivalis has been detected
in the amniotic fluid of pregnant females at risk for premature delivery137,138 and in the placentas of patients with
preeclampsia.139 Immunohistochemistry techniques have
shown that the microbe has a demonstrated presence in placental tissues, for example, syncytiotrophoblasts, chorionic
trophoblasts, decidual cells, amniotic epithelial cells, and
endothelial cells, obtained from subjects diagnosed with
chorioamnionitis. Last, animal studies have demonstrated the
ability of Po. gingivalis to achieve transplacental passage,
resulting in chorioamnionitis and placentitis.140,141
A third conceivable pathway for establishment of oral
microbial pathogens in the vaginal, microbiome which, in a
pregnancy may contribute to the placental microbiome, can
be explained by direct transmission through sexual practices.
This latter pathway does not seem to have been addressed in
the research literature.
Regardless of the origin, infections leading to adverse
pregnancy outcomes that involve bacteria common to the
oral cavity raise at least two relevant questions from a public
health viewpoint:
1. Will preconception treatment of periodontal disease,
that is, reduction of inflammation, bacterial loads, and
inflammatory mediators, in a reproductive age female,
reduce the incidence of adverse pregnancy outcomes?
2. Given the possibility of transmission of oral pathogenic
microbes during sexual activities, will preconception
treatment of periodontal disease in both partners reduce
the incidence of adverse pregnancy outcomes?
Given the cost of dental care in the US and some other
developed countries, the maldistribution of dental practitioners in urban vs rural localities, and the lack of dental care
in many underdeveloped countries, a profound disparity
exists in access to dental care and in periodontal health in
poor and/or rural populations.142–150 Assuming that research
initiatives will eventually answer the two questions listed
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above, the medical and dental public health communities still
need to develop strategies to address access to care.

Conclusion
Significant evidence supports an association between the dissemination of pathogenic bacteria associated with moderate
and severe periodontitis and extraoral infections and inflammation. The virulence properties assigned to specific oral pathogenic bacteria, for example, Fu. nucleatum, Po. gingivalis,
Fi. alocis, C. rectus, and others, render them as potential
collaborators in adverse outcomes of pregnancy.21,151–154 The
biologic plausibility of the association between periodontal
disease, the inherent bacteria and systemic impact of inflammatory mediators, and adverse pregnancy outcomes likely
involves several pathways: 1) a hematogenous spread (bacteremia) of periodontal pathogens;151 2) a hematogenous spread
of multiple mediators of inflammation that are generated by the
host and/or fetal immune response to pathogenic bacteria;116,155
and 3) a possible oral microbial pathogen transmission, with
subsequent colonization, in the vaginal microbiome resulting
from sexual practices. The medical and dental public health
communities should address intervention strategies aimed at
controlling oral inflammatory disease, which will lessen the
systemic inflammatory burden and suppress the potential for
adverse pregnancy outcomes.
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